Clinical features | Level | n | % |
---|---|---|---|
Gender | Female | 23 | 39.0 |
Male | 36 | 61.0 | |
Age, median (range) (years) | 73 (48–91) | ||
Age | ≤67 | 16 | 27.1 |
68–80 | 28 | 47.5 | |
≥81 | 15 | 25.4 | |
TNM stage | IA | 42 | 71.2 |
IB | 16 | 27.1 | |
IIA | 1 | 1.7 | |
T stage | 1A or 1B | 42 | 71.2 |
2A or 2B | 17 | 28.8 | |
Smokera | No | 42 | 72.4 |
Yes | 16 | 27.6 | |
Pack-years smokinga | median (range) | 58 (15–200) | |
≤40 | 14 | 25.0 | |
41–79 | 27 | 48.2 | |
≥80 | 15 | 26.8 | |
O2 dependence | No | 45 | 79.0 |
Yes | 12 | 21.1 | |
ECOG | 0 or 1 | 49 | 84.5 |
2 or 3 | 9 | 15.5 | |
CCI, median (range) | 6 (3–12) | ||
CCI | ≤4 | 18 | 30.5 |
5–7 | 28 | 47.5 | |
≥8 | 13 | 22.0 | |
Dose/Fx | 7.5 | 1 | 1.7 |
10 | 54 | 91.5 | |
12 | 4 | 6.8 | |
Pathology | adenocarcinoma | 26 | 44.1 |
squamous cell carcinoma | 21 | 35.6 | |
NSCLC | 10 | 16.9 | |
large cell carcinoma | 2 | 3.4 |